Cutaneous clues to diagnosis: the vasculopathic form of anti-MDA5dermatomyositis

Anti- melanocyte differentiation-associated protein 5 (MDA5) associated dermatomyositis is a rare, heterogeneous disease with multiple phenotypes. This case describes a patient with indolent myopathy, skin lesions and normal creatine kinase (CK). After a period of diagnostic uncertainty, the patient was found to have positive anti-MDA5 and anti-Ro52 antibodies, confirming anti-MDA5 dermatomyositis with cutaneous vasculopathy. Recognition of vasculopathy as a manifestation of dermatomyositis could have led to a much earlier diagnosis. The European Alliance of Associations for Rheumatology /American College of Rheumatology classification criteria can aid diagnosis. Antibody profile correlates with disease phenotype in dermatomyositis. Anti-MDA5 dermatomyositis is typically associated with rapidly progressive interstitial lung disease and amyopathic dermatomyositis. Some patients may present with myopathy despite a normal CK. Vasculopathic skin lesions are common, but frequently under-recognised, and can develop from Gottron's papules. All phenotypes are associated with increased morbidity and mortality. This underscores the importance of recognising such vasculopathy as a sign of anti-MDA5-associated dermatomyositis, thus contributing to earlier diagnosis and treatment.

Authors

Institutions

Publication Details

Journal
BMJ Case Reports
Published
2026-03-01
DOI
https://doi.org/10.1136/bcr-2025-268344
Primary Topic
Inflammatory Myopathies and Dermatomyositis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cutaneous clues to diagnosis: the vasculopathic form of anti-MDA5dermatomyositis

Yee Chiu, Rikesh Patel, Martin Regan, James Culley
BMJ Case Reports
Inflammatory Myopathies and Dermatomyositis
article

Cutaneous clues to diagnosis: the vasculopathic form of anti-MDA5dermatomyositis

Yee Chiu, Rikesh Patel, Martin Regan, James Culley
article en

Abstract

Anti- melanocyte differentiation-associated protein 5 (MDA5) associated dermatomyositis is a rare, heterogeneous disease with multiple phenotypes. This case describes a patient with indolent myopathy, skin lesions and normal creatine kinase (CK). After a period of diagnostic uncertainty, the patient was found to have positive anti-MDA5 and anti-Ro52 antibodies, confirming anti-MDA5 dermatomyositis with cutaneous vasculopathy. Recognition of vasculopathy as a manifestation of dermatomyositis could have led to a much earlier diagnosis. The European Alliance of Associations for Rheumatology /American College of Rheumatology classification criteria can aid diagnosis. Antibody profile correlates with disease phenotype in dermatomyositis. Anti-MDA5 dermatomyositis is typically associated with rapidly progressive interstitial lung disease and amyopathic dermatomyositis. Some patients may present with myopathy despite a normal CK. Vasculopathic skin lesions are common, but frequently under-recognised, and can develop from Gottron's papules. All phenotypes are associated with increased morbidity and mortality. This underscores the importance of recognising such vasculopathy as a sign of anti-MDA5-associated dermatomyositis, thus contributing to earlier diagnosis and treatment.

BMJ Case ReportsVol. 19(3)
Manchester University NHS Foundation Trust (GB)
Good health and well-being
Openalex Percentile: Top 10%
Inflammatory Myopathies and Dermatomyositis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cutaneous clues to diagnosis: the vasculopathic form of anti-MDA5dermatomyositis — Yee Chiu, Rikesh Patel, et al. · BMJ Case Reports (2026) | TGRS Research Map | TGRS